chronvac-c
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00563173)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis C virusImmunity, active
Hepatitis C virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- chronvac-c
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01335711 | Phase 2 | Apr 1, 2011 | ChronTech Pharma AB, Inovio Pharmaceuticals, Karolinska Institute |
| NCT00563173 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2007 | ChronTech Pharma AB, Inovio Pharmaceuticals, Karolinska Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ChronTech Pharma AB | For profit | 2 | 2 | 1 | 2007 |
| Inovio Pharmaceuticals | For profit | 2 | 0 | 1 | 2007 |
| Karolinska Institute | Academic/Hospital | 2 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1